Stay updated on Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.5.4 is now shown on the page, replacing the previous revision v3.5.3 and signaling a new version of the page.
    Difference
    0.0%
    Check dated 2026-05-18T03:23:15.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The website’s revision/build label for the ClinicalTrials.gov page was updated from v3.5.2 to v3.5.3, indicating a backend or UI version change rather than a change to the displayed study content.
    Difference
    0.0%
    Check dated 2026-04-26T15:27:54.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T13:45:33.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Added the Lancet Oncology publication citation for SERENA-2 and removed the associated Erratum reference.
    Difference
    0.0%
    Check dated 2026-04-05T06:18:14.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Naples, Italy, 80131 was added as a study location and Napoli, Italy, 80131 was replaced with the English name Naples. The page revision was updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T16:55:24.000Z thumbnail image
  9. Check
    85 days ago
    Change Detected
    Summary
    Publication entry for SERENA-2 (Lancet Oncol. 2024) and its erratum added; the entry revision updated from v3.4.2 to v3.4.3 to reflect this change.
    Difference
    0.1%
    Check dated 2026-03-07T13:00:44.000Z thumbnail image

Stay in the know with updates to Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page.